コンテンツへスキップ
Merck
  • Meta-analysis: efficacy of small bowel preparation for small bowel video capsule endoscopy.

Meta-analysis: efficacy of small bowel preparation for small bowel video capsule endoscopy.

Current medical research and opinion (2012-11-10)
Jonathan Belsey, Cristiano Crosta, Owen Epstein, Wolfgang Fischbach, Peter Layer, Fabrizio Parente, Marc Halphen
要旨

It is unclear whether small bowel visibility in video capsule endoscopy (VCE) is enhanced by the use of bowel preparation in addition to pre-procedural fasting. The objective of this study was to clarify this issue by means of a systematic review of the literature and meta-analysis. Randomised controlled trials comparing the use of laxative bowel preparation with fasting alone were identified using a literature search. Categorical measures of treatment efficacy were extracted from qualifying studies and pooled using random-effects meta-analyses. Primary analysis compared any bowel preparation with fasting alone; subsidiary analyses assessed diagnostic yield and results for each regimen. Eight studies were identified, using either polyethylene glycol (PEG) or sodium phosphate (NaP) based regimens. No qualifying studies were identified using other laxatives. Study quality was sufficiently high to warrant meta-analysis. Use of any form of bowel preparation yielded significantly better visibility than fasting alone (OR = 2.31; 95% CI = 1.46-3.63; p < 0.0001). Similar results were seen for diagnostic yield (OR = 1.88; 95% CI = 1.24-2.84; p = 0.023). When sub-analysed according to the treatment used, PEG-based regimens showed benefit (OR = 3.11; 95% CI = 1.96-4.94; p < 0.0001), while NaP-based regimens yielded no significant difference from fasting alone (OR = 1.32; 95% CI = 0.59-2.96; p < 0.0001). The study did not consider results from retrospective studies, nor those which did not give a categorical measure of efficacy. The impact of prokinetic and other adjunctive treatments was not considered. The results are only relevant to the most commonly used video capsule, as data for newer alternative devices have not yet been published. Based on the results of this analysis, the use of bowel preparation alongside fasting is recommended for VCE. PEG-based regimens offer a clear advantage in these patients, while the currently available evidence base does not support the use of NaP. For VCE, lower volume PEG appears to be as efficacious as higher volumes traditionally used for colonoscopy preparation.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
リン酸ナトリウム 二塩基性, ACS reagent, ≥99.0%
Sigma-Aldrich
リン酸ナトリウム 二塩基性 七水和物, ACS reagent, 98.0-102.0%
Sigma-Aldrich
リン酸ナトリウム 二塩基性, puriss. p.a., ACS reagent, anhydrous, ≥99.0% (T)
Sigma-Aldrich
リン酸ナトリウム 一塩基性, ReagentPlus®, ≥99.0%
Sigma-Aldrich
リン酸ナトリウム 二塩基性, puriss., meets analytical specification of Ph. Eur., BP, USP, FCC, E 339, anhydrous, 98-100.5% (calc. to the dried substance)
Sigma-Aldrich
リン酸ナトリウム 二塩基性 十二水和物, meets analytical specification of Ph. Eur., BP, E339, 98.5-102.5% (T)
Sigma-Aldrich
三塩基性リン酸ナトリウム 十二水和物, ACS reagent, ≥98%
Sigma-Aldrich
リン酸ナトリウム, 96%
Sigma-Aldrich
リン酸ナトリウム 一塩基性, BioReagent, Molecular Biology, anhydrous, ≥98%
Sigma-Aldrich
リン酸ナトリウム 二塩基性, ReagentPlus®, ≥99.0%
Sigma-Aldrich
リン酸ナトリウム 一塩基性, BioPerformance Certified, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, ≥99.0% (titration)
Sigma-Aldrich
リン酸ナトリウム 二塩基性, BioReagent, suitable for cell culture, suitable for insect cell culture, ≥99.0%
Sigma-Aldrich
三塩基性リン酸ナトリウム 十二水和物, ≥98%
Supelco
Phosphate Standard for IC, TraceCERT®, 1000 mg/L phosphate in water (nominal concentration)
Sigma-Aldrich
リン酸ナトリウム 二塩基性, BioXtra, ≥99.0%
Sigma-Aldrich
リン酸ナトリウム 二塩基性, Molecular Biology, ≥98.5% (titration)
Sigma-Aldrich
リン酸ナトリウム 二塩基性 十二水和物, puriss. p.a., crystallized, ≥99.0% (T)
Sigma-Aldrich
リン酸ナトリウム 二塩基性 十二水和物, BioXtra, ≥99.0% (T)
Sigma-Aldrich
リン酸水素二ナトリウム 溶液, BioUltra, 0.5 M in H2O
Sigma-Aldrich
リン酸ナトリウム 一塩基性, meets USP testing specifications, anhydrous
Sigma-Aldrich
リン酸ナトリウム 一塩基性, purum p.a., anhydrous, ≥99.0% (T)
Sigma-Aldrich
リン酸ナトリウム, 一塩基酸 溶液, BioUltra, 5 M in H2O
Sigma-Aldrich
リン酸ナトリウム 一塩基性, BioXtra, ≥99.0%
Sigma-Aldrich
リン酸ナトリウム 二塩基性 七水和物, meets USP testing specifications
Sigma-Aldrich
リン酸ナトリウム 二塩基性 七水和物, ≥99.99% trace metals basis
Sigma-Aldrich
リン酸ナトリウム 二塩基性, 99.95% trace metals basis
Sigma-Aldrich
リン酸ナトリウム 二塩基性 十二水和物, tested according to Ph. Eur.
Sigma-Aldrich
リン酸ナトリウム 二塩基性, BioUltra, Molecular Biology, ≥99.5% (T)
Sigma-Aldrich
三塩基性リン酸ナトリウム 十二水和物, puriss. p.a., ACS reagent, ≥98.0% (T)
Sigma-Aldrich
三塩基性リン酸ナトリウム 十二水和物, BioXtra, ≥98.0% (titration)